CTLA4 and colitis: The overall occurrence varies between 0 to 6.3 months.37 Regarding the therapy considered, CTLA-4 inhibitors appear to cause a later onset of colitis than PD-1/PD-L1 inhibitors, whereas the combination of the 2 seem to lead to the earliest incidence.